Boston Scientific reported Q3 2025 net sales of $5.07 billion and adjusted EPS of $0.75, topping expectations and supporting its upbeat full-year guidance.The post Boston Scientific Reports Strong Q3 2025 Results, Raises Full-Year Outlook appeared first on Tokenist.